Efficacy of novel benznidazole solutions during the experimental infection with Trypanosoma cruzi

被引：9

作者：

Manarin, Romina ^{[1
,2
]}

Lamas, Maria C. ^{[3
,4
]}

Bottasso, Emanuel ^{[1
]}

Serra, Esteban ^{[2
]}

Revelli, Silvia ^{[1
]}

Salomon, Claudio J. ^{[3
,4
]}

机构：

[1] Fac Ciencias Med, Inst Inmunol, RA-2000 Rosario, Santa Fe, Argentina

[2] IBR CONICET, Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Santa Fe, Argentina

[3] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Area Tecnol Farmaceut, RA-2000 Rosario, Santa Fe, Argentina

[4] IQUIR CONICET, Inst Quim Rosario, RA-2000 Rosario, Santa Fe, Argentina

来源：

PARASITOLOGY INTERNATIONAL | 2013年 / 62卷 / 01期

关键词：

Chagas' disease; Benznidazole; Soluble formulation; In vivo studies; CHAGAS-DISEASE; SYSTEMS;

D O I：

10.1016/j.parint.2012.09.001

中图分类号：

R38 [医学寄生虫学]; Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ; 100103 ;

摘要：

Chagas' disease is caused by the protozoan parasite Trypanosoma cruzi. About 8 million people throughout Latin America are infected causing approximately 10,000 deaths annually. Benznidazole, available as unique 100 mg tablets in many of the endemic countries, is currently the drug of choice for the specific treatment of this condition. Despite of the large number of pediatric patients infected, there are no commercial liquid dosage forms available to treat this trypanosomiasis. This work showed that novel benznidazole-water-polyethylene glycol 400 solutions are active against T. cruzi in a murine model of Chagas' disease. Present results constitute the first demonstration on the usefulness of benznidazole solutions in infected mice. (C) 2012 Elsevier Ireland Ltd. All rights reserved.

引用

页码：79 / 81

页数：3

共 11 条

[1] Chagas' disease: an update on immune mechanisms and therapeutic strategies [J].

Boscardin, Silvia Beatriz ;

Troccoli Torrecilhas, Ana Claudia ;

Manarin, Romina ;

Revelli, Silvia ;

Gonzalez Rey, Elena ;

Tonelli, Renata Rosito ;

Silber, Ariel Mariano .

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (6B) :1373-1384

[2] Chagas disease travels to Europe [J].

Ignacio Gonzalez-Granado, Luis ;

Rojo-Conejo, Pablo ;

Ruiz-Contreras, Jesus ;

Gonzalez-Tome, Maria I. .

LANCET, 2009, 373 (9680) :2025-2025

[3] Development of parenteral formulations and evaluation of the biological activity of the trypanocide drug benznidazole [J].

Lamas, MC ;

Villaggi, L ;

Nocito, I ;

Bassani, G ;

Leonardi, D ;

Pascutti, F ;

Serra, E ;

Salomón, CJ .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 307 (02) :239-243

[4] High prevalence of congenital Trypanosoma cruzi infection and family clustering in Salta, Argentina [J].

Negrette, OS ;

Mora, MC ;

Basombrío, MA .

PEDIATRICS, 2005, 115 (06) :E668-E672

[5] New, Improved Treatments for Chagas Disease: From the R&D Pipeline to the Patients [J].

Ribeiro, Isabela ;

Sevcsik, Ann-Marie ;

Alves, Fabiana ;

Diap, Graciela ;

Don, Robert ;

Harhay, Michael O. ;

Chang, Shing ;

Pecoul, Bernard .

PLOS NEGLECTED TROPICAL DISEASES, 2009, 3 (07)

[6] Differential susceptibility to acute Trypanosoma cruzi infection in BALB/c and C57BL/6 mice is not associated with a distinct parasite load but cytokine abnormalities [J].

Roggero, E ;

Perez, A ;

Tamae-Kakazu, M ;

Piazzon, I ;

Nepomnaschy, I ;

Wietzerbin, J ;

Serra, E ;

Revelli, S ;

Bottasso, O .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 128 (03) :421-428

[7] A quantitative structure-property relationship for predicting drug solubility in PEG 400/water cosolvent systems [J].

Rytting, E ;

Lentz, KA ;

Chen, XQ ;

Qian, F ;

Venkatesh, S .

PHARMACEUTICAL RESEARCH, 2004, 21 (02) :237-244

[8] First century of chagas' disease: An overview on novel approaches to nifurtimox and benznidazole delivery systems [J].

Salomon, Claudio J. .

JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (03) :888-894

[9] Epidemiology of Chagas disease in non-endemic countries: the role of international migration [J].

Schmunis, Gabriel A. .

MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2007, 102 :75-85

[10] The need of a neonatal preparation for Chagas disease [J].

Sosa-Estani, S ;

Belizan, JM ;

Althabe, F ;

Rubinstein, A .

PLOS MEDICINE, 2005, 2 (11) :1194-1195

← 1 2 →